Navigation Links
UN Member States jeopardize international progress on non-communicable disease epidemic
Date:8/24/2011

Geneva, 23rd August 2011 The fight against non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease, chronic respiratory disease and liver disease, is at grave risk, because of recent efforts by some countries to stall and weaken critical United Nations negotiations, the European Association for the Study of the Liver (EASL) warned today.

In a letter addressed to Mr Ban Ki-Moon, Dr Margaret Chan and Mr Jose Manuel Barroso, EASL called on them to personally push for progress at the first ever UN High-Level Meeting on the Prevention and Control of Non Communicable Diseases, scheduled for 19󈞀 September in New York.

"The situation is urgent," said Prof. Mark Thursz, Secretary General of EASL. "Sound proposals for clear goals and timelines to tackle devastating diseases, including liver disease, are being systematically deleted, diluted and downgraded by some member states. Urgent action is needed now to put the negotiations back on track."

NCDs are the leading cause of death worldwide each year, causing 36 million deaths in 2008 and accounting for 63 per cent of all global deaths (1). Over the next 20 years, the NCD epidemic is projected to accelerate exponentially, putting enormous strain on families, health systems and economies.

In Europe alone, 86% of all deaths are caused by chronic non-communicable diseases with up to 80% of health-care expenses being allocated to them. What is worse is the fact that the majority of chronic non-communicable diseases can be prevented.

Liver disease is estimated to affect 6% of the EU's population (approx. 29 million people) and is reported to be the EU's 5th biggest killer, accounting for at least one in six deaths. In 2004, the mortality rate for chronic liver diseases was estimated at 14.3 per 100.000 in the EU-25. This means that more than 70,000 Europeans are dying from chronic liver diseases every year. Even more worrying is the fact that the EU statistics do not cover all disease of the liver in one category, e.g. alcohol abuse related deaths and liver cancer are treated separately. Therefore, the actual rate of deaths from liver diseases is certainly much higher than the statistics suggest.

And yet, says EASL, the NCD epidemic could be effectively addressed through the reduction of risk factors principally tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol as well as early detection and timely treatments.

"We have a unique and historic opportunity to change the course of this ticking time bomb and stop millions of people around the world suffering unnecessary pain and hardship", said Prof. Dominique-Charles Valla, EASL's EU Policy Councillor. "To do that, we need governments to agree and act on a common goal."

EASL is calling on the High Level Meeting to agree on:

  • An overarching goal to reduce preventable deaths from NCDs by 25% by 2025
  • A clear timeline for tackling the epidemic of major NCDs, including liver disease
  • A set of specific, evidence-based targets and global indicators
  • A high-level collaborative initiative of governments and UN agencies with civil society to stimulate and assess progress.


'/>"/>

Contact: Margaret Walker
margaret.walker@easloffice.eu
41-799-461-549
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. UC Riverside faculty member elected fellow of Entomological Society of America
2. Military Members Face Raised Risk of Osteoarthritis: Study
3. Black members of Adventist church defy health disparities, study shows
4. Three senior Hebrew University faculty members receive Kaye Awards for innovations
5. As time goes by, it gets tougher to just remember this
6. Monkey See, Monkey Remember
7. IUPUI faculty member to receive national innovative vision research award
8. Smarter systems help busy doctors remember
9. Family Members Caring for Veterans Sacrifice Their Own Health, Jobs
10. ASTRO names radiologist, ABR president Societys 2010 Honorary Member
11. 2010 Resource Planning Summit to offer $695 Registration Fee for PDMA, PMI, BIOCOM and ASAPM Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: